ClosedHealth & Human Services
Infant, Child, and Adolescent Preventive Services (ICAPS) Program with Additional Funding for Early Hearing Detection and Intervention Activities
Health Resources and Services AdministrationHRSA-23-074
Description
The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year (FY) 2023 Infant, Child, and Adolescent Preventive Services (ICAPS) Program. The purpose of this program is to help care providers1 and care teams provide optimal health promotion and preventive services to infants, children, adolescents, young adults and their families. This Program accomplishes this purpose through two sets of program expectations and requirements:
1) Bright Futures Pediatric Implementation: Reviews evidence to support recommendations for updated evidence-based preventive services guidelines for infants, children, and adolescents, as well as advancement of innovations in health promotion and preventive services for these populations. Included in this activity is evidence review and recommendations to HRSA for evidence-informed preventive care and screening for infants, children, and adolescents for which, upon HRSA’s approval, under § 2713 of the Public Health Service Act, 42 U.S.C. § 300gg-13, certain insurance companies are required to provide insurance coverage without cost-sharing.
2) Advancing Systems/Technical Assistance (TA) for Healthy Tomorrows, Healthy Tomorrows Resource Center: Provides technical assistance to entities receiving HRSA grant funding under the Healthy Tomorrows program (HRSA-17-008, HRSA-19-055, and HRSA-21-031) to assist such entities in carrying out such grant awards.
Early Hearing Detection and Intervention (EHDI): Provides training and educates providers caring for infants and children who are deaf or hard of hearing, as well as state/territory Early Hearing Detection and Intervention (EHDI) programs, on evidence-based practice to ensure that these infants, children and their families have timely access to early intervention and comprehensive care.
For more details, see Program Requirements and Expectations.
Award Ceiling
$1.6M
Total Funding
$1.6M
CFDA Number
93.110
Funding Instrument
Cooperative Agreement
Funding Level
Federal
Jurisdiction
US
Cost Sharing
No
Open Date
September 14, 2022
Close Date
December 14, 2022
Posted Date
September 14, 2022
Eligible Applicant Types
County governmentsPublic and State controlled institutions of higher educationState governmentsOthers (see text field entitled "Additional Information on Eligibility" for clarification)City or township governmentsSpecial district governmentsIndependent school districtsNative American tribal organizations (other than Federally recognized tribal governments)For profit organizations other than small businessesPrivate institutions of higher educationNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Tags
HHS-HRSACFDA:93.110Cooperative AgreementHealth
Related Health & Human Services Grants
NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
National Institutes of Health
0d left
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
National Institutes of Health
0d left
HIV Prevention and Alcohol (R01 Clinical Trials Optional)
National Institutes of Health
0d left
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
National Institutes of Health
0d left